Regulatory Approvals

FDA Approves First Disease-Modifying Treatment for AxD

By

Regulatory Approvals — FDA Approves First Disease-Modifying Treatment for AxD  The American Journal of Managed Care

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 8, 2026.

By

Related Post

Regulatory Approvals

Recon: FDA approves AZ’s breast cancer drug over negative adcomm vote; Novartis sees setbacks for drugs targeting cholesterol, myotonic dystrophy

Regulatory Approvals

Abbott earns FDA approval for new dual-energy ablation catheter

Regulatory Approvals

Why a cannabis business is betting on dogs to reach FDA approval

Financial News For All

Labor

Thousands of Chicago hotel workers threaten to strike

Labor

Nurses throughout Jefferson Health System announce plan to unionize

Labor

More than 200 registered nurses at Jefferson Health in Greater Philadelphia announce plans to unionize

Regulatory Approvals

Abbott earns FDA approval for new dual-energy ablation catheter